Deciphering white matter to enable better care
Location: France, Grand Est, Strasbourg
Employees: 1-10
Total raised: $6.12M
Founded date: 2018
Investors 1
| Date | Name | Website |
| 13.11.2023 | Capital Gr... | capitalgra... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 20.06.2023 | - | $4.92M | - |
| 08.11.2020 | Seed | $1.2M | - |
Mentions in press and media 3
| Date | Title | Description |
| 20.06.2023 | BrainTale raises €4.5M to develop solutions for diagnosis, monitoring, prediction of Neurological disorders | Paris-based BrainTale, a medtech company that develops and distributes diagnosis and prognosis tools that decipher white matter to enable better brain care, announced on Tuesday that it has secured €4.5M in a fresh round of funding. The inv... |
| 20.06.2023 | BrainTale Raises €4.5M in Funding | BrainTale, a Strasbourg, France-based medtech company focused on improving brain care, raised €4.5M in funding. The round was led by Capital Grand Est and MACSF. The company intends to use the funds to accelerate its expansion in Europe and... |
| 18.03.2021 | BrainTale Announces the CE Marking of New brainQuant Release and Supports the 1st World Coma Day on March 22nd, 2021 | PARIS--(BUSINESS WIRE)--Mar 18, 2021-- BrainTale, an innovative French company dedicated to enabling improved care for brain-injured patients in clinical routine with its portfolio of digital medical devices in neurology and intensive care,... |